ArticleAnnals of medicine and surgery (2012)2026

Off-label GLP-1 receptor agonist and tirzepatide use for weight loss: patient safety and regulatory oversight.

Areesha Maqsood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.